CAI
Caris Life Sciences Inc.

802
Mkt Cap
$7.2B
Volume
2.74M
52W High
$42.50
52W Low
$21.00
Price
$25.61
CAI Fundamentals
Prev Close
$24.61
Open
$24.22
50D MA
$31.76
Beta
-1.12
Avg. Volume
680,621.74
EPS (Annual)
-$1.35
P/B
15.10
Loading...
Loading...
News
all
press releases
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response PR...
PR Newswire·11d ago
News Placeholder
More News
News Placeholder
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025 Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025 PR Newswire IRVING...
PR Newswire·17d ago
News Placeholder
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025 Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025 PR Newswire IRVING, Texas, Oct. 14, 2025 IRVING, Texas, Oct...
PR Newswire·26d ago
News Placeholder
TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape
Tempus AI's PurIST test secures clinical validation, helping personalize treatment choices for advanced pancreatic cancer patients.
Zacks·2mo ago
News Placeholder
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI...
PR Newswire·3mo ago

Latest CAI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.